Osaka, Japan

Yasuhiro Fujino

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Yasuhiro Fujino - A Pioneer in Monoclonal Antibody Research

Introduction

Yasuhiro Fujino is an accomplished inventor based in Osaka, Japan, known for his significant contributions to the field of biotechnology. With an impressive portfolio of four patents, Fujino has made strides in the development of human monoclonal antibodies, demonstrating his expertise and innovative spirit in medical science.

Latest Patents

Fujino's latest patents focus on the creation of human anti-IL-33 neutralizing monoclonal antibodies. These antibodies are designed to exhibit antagonistic effects against interleukin-33 (IL-33), a cytokine involved in various inflammatory diseases. The patents detail the isolation of these antibodies, highlighting their framework regions composed of specific amino acid sequences derived from germline configurations. Moreover, the identification of epitopes for several anti-IL-33 monoclonal antibodies underlines the thorough research conducted to enhance the binding ability of these crucial elements by introducing targeted mutations in the complementarity-determining regions.

Career Highlights

Fujino has an illustrious career, notably working with Mitsubishi Tanabe Pharma Corporation and The University of Tokyo. His experience at these prestigious organizations has equipped him with a strong foundation in pharmaceutical research and development, allowing him to contribute significantly to advancements in antibody therapeutics.

Collaborations

Throughout his career, Fujino has collaborated with esteemed colleagues, including Tsutomu Yoshikawa and Hiroshi Ochi. These collaborations have fostered a dynamic exchange of ideas and insights, propelling the progress of their collective research endeavors in the biopharmaceutical arena.

Conclusion

Yasuhiro Fujino's innovative work in monoclonal antibody development exemplifies the impact of dedicated inventors in the field of biotechnology. His patents not only represent significant scientific achievements but also pave the way for new therapeutic options for patients facing inflammatory conditions. Fujino's ongoing contributions affirm his status as a leading figure in the research community, making remarkable strides towards advancing medical science and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…